Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. N Engl J Med.1993;329:247-256.
Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol.1988;158:1553-1560, 1566-1567.
Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction:
biology or methodology? JAMA.1990;263:1092-1096.
White HD, Barbash GI, Modan M.
et al. for the Investigators of the International Tissue Plasminogen Activator/Streptokinase
Mortality Study. After correcting for worse baseline characteristics, women treated
with thrombolytic therapy for acute myocardial infarction have the same mortality
and morbidity as men except for a higher incidence of hemorrhagic stroke. Circulation.1993;88:2097-2103.
Becker RC, Terrin M, Ross R.
et al. for the Thrombolysis in Myocardial Infarction Investigators. Comparison of clinical outcomes for women and men after acute myocardial
infarction. Ann Intern Med.1994;120:638-645.
Stone PH, Thompson B, Anderson HV.
et al. Influence of race, sex, and age on management of unstable angina and
non-Q-wave myocardial infarction: the TIMI III registry. JAMA.1996;275:1104-1112.
Malacrida R, Genoni M, Maggioni AP.
et al. for the Third International Study of Infarct Survival Collaborative
Group. A comparison of the early outcome of acute myocardial infarction in
women and men. N Engl J Med.1998;338:8-14.
Hochman JS, Tamis JE, Thompson TD.
et al. for the Global Use of Strategies to Open Occluded Coronary Arteries
in Acute Coronary Syndromes IIb Investigators. Sex, clinical presentation, and outcome in patients with acute coronary
syndromes. N Engl J Med.1999;341:226-232.
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction:
National Registry of Myocardial Infarction 2 Participants. N Engl J Med.1999;341:217-225.
Roger VL, Farkouh ME, Weston SA.
et al. Sex differences in evaluation and outcome of unstable angina. JAMA.2000;283:646-652.
Healy B. The Yentl syndrome. N Engl J Med.1991;325:274-276.
Mark DB. Sex bias in cardiovascular care: should women be treated more like
Steingart RM, Packer M, Hamm P.
et al. for the Survival and Ventricular Enlargement Investigators. Sex differences in the management of coronary artery disease. N Engl J Med.1991;325:226-230.
Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized
for coronary heart disease. N Engl J Med.1991;325:221-225.
Kostis JB, Wilson AC, O'Dowd K.
et al. for the MIDAS Study Group: Myocardial Infarction Data Acquisition System. Sex differences in the management and long-term outcome of acute myocardial
infarction: a statewide study. Circulation.1994;90:1715-1730.
Maynard C, Beshansky JR, Griffith JL, Selker HP. Influence of sex on the use of cardiac procedures in patients presenting
to the emergency department: a prospective multicenter study. Circulation.1996;94(suppl 9):II93-II98.
Krumholz HM, Douglas PS, Lauer MS, Pasternak RC. Selection of patients for coronary angiography and coronary revascularization
early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med.1992;116:785-790.
Mark DB, Shaw LK, DeLong ER, Califf RM, Pryor DB. Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med.1994;330:1101-1106.
Fisher LD, Kennedy JW, Davis KB.
et al. Association of sex, physical size, and operative mortality after coronary
artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg.1982;84:334-341.
Rahimtoola SH, Bennett AJ, Grunkemeier GL, Block P, Starr A. Survival at 15 to 18 years after coronary bypass surgery for angina
in women. Circulation.1993;88(5 pt 2):II71-II78.
O'Connor GT, Morton JR, Diehl MJ.
et al. for the Northern New England Cardiovascular Disease Study Group. Differences between men and women in hospital mortality associated
with coronary artery bypass graft surgery. Circulation.1993;88:2104-2110.
Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women:
1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty
Bell MR, Grill DE, Garratt KN, Berger PB, Gersh BJ, Holmes Jr DR. Long-term outcome of women compared with men after successful coronary
Malenka DJ, O'Connor GT, Quinton H.
et al. for the Northern New England Cardiovascular Disease Study Group. Differences in outcomes between women and men associated with percutaneous
transluminal coronary angioplasty: a regional prospective study of 13,061
procedures. Circulation.1996;94(suppl 9):II99-II104.
Topol EJ. Coronary-artery stents: gauging, gorging, and gouging. N Engl J Med.1998;339:1702-1704.
Serruys PW, De Jaegere P, Kiemeneij F.
et al. A comparison of balloon-expandable-stent implantation with balloon
angioplasty in patients with coronary artery disease. N Engl J Med.1994;331:489-495.
Fischman DL, Leon MB, Baim DS.
et al. A randomized comparison of coronary-stent placement and balloon angioplasty
in the treatment of coronary artery disease. N Engl J Med.1994;331:496-501.
Savage MP, Douglas Jr JS, Fischman DL.
et al. Stent placement compared with balloon angioplasty for obstructed coronary
bypass grafts. N Engl J Med.1997;337:740-747.
Erbel R, Haude M, Hopp HW.
et al. Coronary-artery stenting compared with balloon angioplasty for restenosis
after initial balloon angioplasty. N Engl J Med.1998;339:1672-1678.
Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. A comparison of coronary-artery stenting with angioplasty for isolated
stenosis of the proximal left anterior descending coronary artery. N Engl J Med.1997;336:817-822.
Van Belle E, Bauters C, Hubert E.
et al. Restenosis rates in diabetic patients: a comparison of coronary stenting
and balloon angioplasty in native coronary vessels. Circulation.1997;96:1454-1460.
Schömig A, Kastrati A, Mudra H.
et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty
complicated by dissection with threatened or present vessel closure. Circulation.1994;90:2716-2724.
Schömig A, Neumann FJ, Kastrati A.
et al. A randomized comparison of antiplatelet and anticoagulant therapy after
the placement of coronary artery stents. N Engl J Med.1996;334:1084-1989.
The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med.1985;312:932-936.
Ellis SG, Vandormael MG, Cowley MJ.
et al. Coronary morphologic and clinical determinants of procedural outcome
with angioplasty for multivessel coronary disease: implications for patient
Kastrati A, Schömig A, Elezi S.
et al. Prognostic value of the modified American College of Cardiology/American
Heart Association stenosis morphology classification for long-term angiographic
and clinical outcome after coronary stent placement. Circulation.1999;100:1285-1290.
Rutherford JD, Braunwald E, Cohn PF. Chronic ischemic heart disease. In: Braunwald E, ed. Heart Disease: A Textbook
of Cardiovascular Medicine. 3rd ed. Philadelphia, Pa: WB Saunders Company;
Mathsoft Inc. Classification and regression trees. In: S-Plus 2000 Guide to Statistics. Seattle,
Wash: Data Analysis Products Division, Mathsoft Inc; 1999:369-401.
Topol EJ, Mark DB, Lincoff AM.
et al. for the EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Outcomes at
1 year and economic implications of platelet glycoprotein IIb/IIIa blockade
in patients undergoing coronary stenting: results from a multicentre randomised
Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA.1991;265:1861-1867.
Jayes Jr RL, Beshansky JR, D'Agostino RB, Selker HP. Do patients' coronary risk factor reports predict acute cardiac ischemia
in the emergency department: a multicenter study. J Clin Epidemiol.1992;45:621-626.
Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes:
a 26-year follow-up of the Framingham population. Am Heart J.1986;111:383-390.
Schühlen H, Kastrati A, Dirschinger J.
et al. Intracoronary stenting and risk for major adverse cardiac events during
the first month. Circulation.1998;98:104-111.
Cowley MJ, Mullin SM, Kelsey SF.
et al. Sex differences in early and long-term results of coronary angioplasty
in the NHLBI PTCA Registry. Circulation.1985;71:90-97.
Weintraub WS, Wenger NK, Kosinski AS.
et al. Percutaneous transluminal coronary angioplasty in women compared with
men. J Am Coll Cardiol.1994;24:81-90.
Kastrati A, Schömig A, Seyfarth M.
et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis
after coronary stent placement. Circulation.1999;99:1005-1110.
Jacobs AK, Kelsey SF, Brooks MM.
et al. Better outcome for women compared with men undergoing coronary revascularization:
a report from the bypass angioplasty revascularization investigation (BARI). Circulation.1998;98:1279-1285.
Bell MR, Holmes Jr DR, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous
transluminal coronary angioplasty. JAMA.1993;269:2091-2095.
Jacobs AK, Kelsey SF, Yeh W.
et al. Documentation of decline in morbidity in women undergoing coronary
angioplasty: a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary
Angioplasty Registry. Am J Cardiol.1997;80:979-984.
Marso SP, Lincoff AM, Ellis SG.
et al. Optimizing the percutaneous interventional outcomes for patients with
diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa
inhibitor for stenting trial) diabetic substudy. Circulation.1999;100:2477-2484.